This is a StreetInsider.com Premium Only Page

(MGTX) –

Apr 24, 2024 04:30 PM MeiraGTx to Participate in Upcoming Investor Conferences

Apr 18, 2024 04:30 PM MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference

Apr 16, 2024 04:57 PM Form 8-K/A MeiraGTx Holdings plc For: Apr 25

Apr 8, 2024 04:54 PM Form 4 MeiraGTx Holdings plc For: Apr 05 Filed by: Forbes Alexandria

Mar 15, 2024 09:01 AM Form 10-K MeiraGTx Holdings plc For: Dec 31

Mar 14, 2024 04:52 PM Form 4 MeiraGTx Holdings plc For: Mar 12 Filed by: Forbes Alexandria

Mar 14, 2024 09:16 AM Form 8-K MeiraGTx Holdings plc For: Mar 14

Mar 14, 2024 08:30 AM MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates

Mar 4, 2024 06:10 PM Form 4 MeiraGTx Holdings plc For: Feb 29 Filed by: Giroux Richard

Feb 14, 2024 04:39 PM Form SC 13D/A MeiraGTx Holdings plc Filed by: PERCEPTIVE ADVISORS LLC

Feb 13, 2024 09:55 AM Form SC 13G/A MeiraGTx Holdings plc Filed by: Prosight Management, LP

Feb 13, 2024 08:11 AM Form 8-K MeiraGTx Holdings plc For: Feb 13

Feb 13, 2024 08:03 AM MeiraGTx Holdings (MGTX) Announces $50 Million Milestone from Janssen Pharmaceuticals

Feb 13, 2024 08:00 AM MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals

Feb 9, 2024 10:14 AM Form SCHEDULE 13G MeiraGTx Holdings plc Filed by: ADENA ESTATE INC.

Feb 7, 2024 07:52 AM Form SC 13G/A MeiraGTx Holdings plc Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.

Feb 1, 2024 07:30 AM Graviton Bioscience Announces Strategic Investment from Sanofi to Advance Development of the Next Generation of Selective ROCK2 Inhibitors

Jan 18, 2024 05:17 PM Form 4/A MeiraGTx Holdings plc For: Jan 07 Filed by: Zeldin Robert K

Jan 17, 2024 07:17 PM Form 4 MeiraGTx Holdings plc For: Jan 14 Filed by: Giroux Richard

Jan 17, 2024 07:16 PM Form 4 MeiraGTx Holdings plc For: Jan 14 Filed by: Zeldin Robert K

Jan 17, 2024 07:15 PM Form 4 MeiraGTx Holdings plc For: Jan 14 Filed by: Forbes Alexandria

Jan 17, 2024 07:14 PM Form 4 MeiraGTx Holdings plc For: Jan 14 Filed by: Naylor Stuart

Jan 17, 2024 07:14 PM Form 4 MeiraGTx Holdings plc For: Jan 14 Filed by: Wollin Robert J

Jan 9, 2024 05:27 PM Form 4 MeiraGTx Holdings plc For: Jan 07 Filed by: Zeldin Robert K

Jan 9, 2024 05:27 PM Form 4 MeiraGTx Holdings plc For: Jan 07 Filed by: Wollin Robert J

Jan 9, 2024 05:26 PM Form 4 MeiraGTx Holdings plc For: Jan 07 Filed by: Naylor Stuart

Jan 9, 2024 05:25 PM Form 4 MeiraGTx Holdings plc For: Jan 07 Filed by: Giroux Richard

Jan 9, 2024 05:24 PM Form 4 MeiraGTx Holdings plc For: Jan 07 Filed by: Forbes Alexandria

Jan 2, 2024 06:08 AM Form EFFECT MeiraGTx Holdings plc

Dec 21, 2023 08:35 AM MeiraGTx Holdings plc (MGTX) Files $250M Mixed Shelf

Dec 21, 2023 08:31 AM Form S-3 MeiraGTx Holdings plc

Dec 21, 2023 07:11 AM Form 8-K MeiraGTx Holdings plc For: Dec 20

Dec 21, 2023 07:02 AM MeiraGTx Holdings plc (MGTX) Reports Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415M

Dec 21, 2023 07:00 AM MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million

Nov 21, 2023 04:30 PM MeiraGTx to Participate in Upcoming Investor Conferences

Nov 15, 2023 08:22 AM MeiraGTx Holdings plc (MGTX) PT Lowered to $19 at BofA Securities

Nov 14, 2023 08:17 AM Form 10-Q MeiraGTx Holdings plc For: Sep 30

Nov 14, 2023 08:07 AM Form 8-K MeiraGTx Holdings plc For: Nov 14

Nov 14, 2023 08:00 AM MeiraGTx Announces Third Quarter 2023 Financial and Operational Results

Nov 6, 2023 07:51 AM Form SC 13G MeiraGTx Holdings plc Filed by: Sanofi

Oct 30, 2023 02:31 PM MeiraGTx's (MGTX) Sanofi deal shows 'significant underappreciated value' in portfolio and capabilities - Piper Sandler

Oct 30, 2023 07:38 AM Form 8-K MeiraGTx Holdings plc For: Oct 30

Oct 30, 2023 07:31 AM MeiraGTx Holdings (MGTX) Announces 4M Share Offering at $7.50/sh, Pursues Multiple Additional Strategic Opportunities

Oct 30, 2023 07:30 AM MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities

Oct 24, 2023 08:30 AM MeiraGTx Announces an Oral Presentation and Eight Posters at the European Society of Gene and Cell Therapy (ESGCT) 2023 Annual Congress

Oct 9, 2023 08:54 AM Piper Sandler highlights 12 biotech takeover targets as M&A 'about as conducive as we've seen'

Sep 18, 2023 11:00 AM Form 3 MeiraGTx Holdings plc For: Sep 15 Filed by: Johnson & Johnson Innovation - JJDC, Inc.

Sep 18, 2023 09:36 AM Form 4 MeiraGTx Holdings plc For: Sep 15 Filed by: Johnson & Johnson Innovation - JJDC, Inc.

Aug 14, 2023 06:06 AM Form EFFECT MeiraGTx Holdings plc

Aug 14, 2023 06:06 AM Form EFFECT MeiraGTx Holdings plc